Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jin Q Cheng

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2011
Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic miceMaria E Balasis, Kara D Forinash, Y Ann Chen, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|September 27, 2008
Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysisJian-Jun Zhao, Juhua Yang, Jianhong Lin, et al.
Molecular Cancer Therapeutics|May 27, 2010
Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cellsBin Zhong, David A Sallman, Danielle L Gilvary, et al.
The Journal of Biological Chemistry|March 24, 2005
ArgBP2gamma interacts with Akt and p21-activated kinase-1 and promotes cell survivalZeng-qiang Yuan, Donghwa Kim, Satoshi Kaneko, et al.
International Journal of Cancer|August 13, 2015
STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancerJennifer Permuth-Wey, William J Fulp, Brett M Reid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancerTatiana M Gritsko, Domenico Coppola, June E Paciga, et al.
The Journal of Biological Chemistry|November 9, 2016
ArgBP2γ interacts with Akt and p21-activated kinase-1 and promotes cell survivalZeng-Qiang Yuan, Donghwa Kim, Satoshi Kaneko, et al.
The Journal of Biological Chemistry|July 5, 2012
Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancerHyun Min Jung, Brittany L Phillips, Rushi S Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2005
Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cellsSangkil Nam, Ralf Buettner, James Turkson, et al.
The Journal of Biological Chemistry|November 9, 2016
Inhibition of JNK by cellular stress- and tumor necrosis factor α-induced AKT2 through activation of the NFκB pathway in human epithelial cellsZeng-Qiang Yuan, Richard I Feldman, Mei Sun, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2011
Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic miceMaria E Balasis, Kara D Forinash, Y Ann Chen, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|September 27, 2008
Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysisJian-Jun Zhao, Juhua Yang, Jianhong Lin, et al.
Molecular Cancer Therapeutics|May 27, 2010
Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cellsBin Zhong, David A Sallman, Danielle L Gilvary, et al.
The Journal of Biological Chemistry|March 24, 2005
ArgBP2gamma interacts with Akt and p21-activated kinase-1 and promotes cell survivalZeng-qiang Yuan, Donghwa Kim, Satoshi Kaneko, et al.
International Journal of Cancer|August 13, 2015
STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancerJennifer Permuth-Wey, William J Fulp, Brett M Reid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancerTatiana M Gritsko, Domenico Coppola, June E Paciga, et al.
The Journal of Biological Chemistry|November 9, 2016
ArgBP2γ interacts with Akt and p21-activated kinase-1 and promotes cell survivalZeng-Qiang Yuan, Donghwa Kim, Satoshi Kaneko, et al.
The Journal of Biological Chemistry|July 5, 2012
Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancerHyun Min Jung, Brittany L Phillips, Rushi S Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2005
Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cellsSangkil Nam, Ralf Buettner, James Turkson, et al.
The Journal of Biological Chemistry|November 9, 2016
Inhibition of JNK by cellular stress- and tumor necrosis factor α-induced AKT2 through activation of the NFκB pathway in human epithelial cellsZeng-Qiang Yuan, Richard I Feldman, Mei Sun, et al.
Pageof 12